Cargando…

A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity

BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet t...

Descripción completa

Detalles Bibliográficos
Autores principales: Balice-Gordon, Rita, Honey, Garry D, Chatham, Christopher, Arce, Estibaliz, Duvvuri, Sridhar, Naylor, Melissa Graham, Liu, Wenlei, Xie, Zhiyong, DeMartinis, Nicholas, Harel, Brian T, Braley, Gabriel H, Kozak, Rouba, Park, Lovingly, Gray, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251631/
https://www.ncbi.nlm.nih.gov/pubmed/32055822
http://dx.doi.org/10.1093/ijnp/pyaa007
_version_ 1783538994843222016
author Balice-Gordon, Rita
Honey, Garry D
Chatham, Christopher
Arce, Estibaliz
Duvvuri, Sridhar
Naylor, Melissa Graham
Liu, Wenlei
Xie, Zhiyong
DeMartinis, Nicholas
Harel, Brian T
Braley, Gabriel H
Kozak, Rouba
Park, Lovingly
Gray, David L
author_facet Balice-Gordon, Rita
Honey, Garry D
Chatham, Christopher
Arce, Estibaliz
Duvvuri, Sridhar
Naylor, Melissa Graham
Liu, Wenlei
Xie, Zhiyong
DeMartinis, Nicholas
Harel, Brian T
Braley, Gabriel H
Kozak, Rouba
Park, Lovingly
Gray, David L
author_sort Balice-Gordon, Rita
collection PubMed
description BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet to be tested in humans. METHODS: Using a novel, exploratory neurofunctional domains study design, we assessed the safety, tolerability, pharmacodynamics, and pharmacokinetics of PF-06412562, a selective D1/D5R partial agonist, in healthy male volunteers who met prespecified criteria for low working memory capacity. Functional magnetic resonance imaging, electrophysiologic endpoints, and behavioral paradigms were used to assess working memory, executive function, and motivation/reward processing following multiple-dose administration of PF-06412562. A total of 77 patients were assigned PF-06412562 (3 mg twice daily and 15 mg twice daily) or placebo administered for 5 to 7 days. Due to the exploratory nature of the study, it was neither powered for any specific treatment effect nor corrected for multiple comparisons. RESULTS: Nominally significant improvements from baseline in cognitive endpoints were observed in all 3 groups; however, improvements in PF-06412562–treated patients were less than in placebo-treated participants. Motivation/reward processing endpoints were variable. PF-06412562 was safe and well tolerated, with no serious adverse events, severe adverse events, or adverse events leading to dose reduction or temporary discontinuation except for 1 permanent discontinuation due to increased orthostatic heart rate. CONCLUSIONS: PF-06412562, in the dose range and patient population explored in this study, did not improve cognitive function or motivation/reward processing more than placebo over the 5- to 7-day treatment period. CLINICALTRIALS.GOV IDENTIFIER: NCT02306876
format Online
Article
Text
id pubmed-7251631
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72516312020-06-02 A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity Balice-Gordon, Rita Honey, Garry D Chatham, Christopher Arce, Estibaliz Duvvuri, Sridhar Naylor, Melissa Graham Liu, Wenlei Xie, Zhiyong DeMartinis, Nicholas Harel, Brian T Braley, Gabriel H Kozak, Rouba Park, Lovingly Gray, David L Int J Neuropsychopharmacol Regular Research Articles BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet to be tested in humans. METHODS: Using a novel, exploratory neurofunctional domains study design, we assessed the safety, tolerability, pharmacodynamics, and pharmacokinetics of PF-06412562, a selective D1/D5R partial agonist, in healthy male volunteers who met prespecified criteria for low working memory capacity. Functional magnetic resonance imaging, electrophysiologic endpoints, and behavioral paradigms were used to assess working memory, executive function, and motivation/reward processing following multiple-dose administration of PF-06412562. A total of 77 patients were assigned PF-06412562 (3 mg twice daily and 15 mg twice daily) or placebo administered for 5 to 7 days. Due to the exploratory nature of the study, it was neither powered for any specific treatment effect nor corrected for multiple comparisons. RESULTS: Nominally significant improvements from baseline in cognitive endpoints were observed in all 3 groups; however, improvements in PF-06412562–treated patients were less than in placebo-treated participants. Motivation/reward processing endpoints were variable. PF-06412562 was safe and well tolerated, with no serious adverse events, severe adverse events, or adverse events leading to dose reduction or temporary discontinuation except for 1 permanent discontinuation due to increased orthostatic heart rate. CONCLUSIONS: PF-06412562, in the dose range and patient population explored in this study, did not improve cognitive function or motivation/reward processing more than placebo over the 5- to 7-day treatment period. CLINICALTRIALS.GOV IDENTIFIER: NCT02306876 Oxford University Press 2020-02-14 /pmc/articles/PMC7251631/ /pubmed/32055822 http://dx.doi.org/10.1093/ijnp/pyaa007 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Articles
Balice-Gordon, Rita
Honey, Garry D
Chatham, Christopher
Arce, Estibaliz
Duvvuri, Sridhar
Naylor, Melissa Graham
Liu, Wenlei
Xie, Zhiyong
DeMartinis, Nicholas
Harel, Brian T
Braley, Gabriel H
Kozak, Rouba
Park, Lovingly
Gray, David L
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title_full A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title_fullStr A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title_full_unstemmed A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title_short A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
title_sort neurofunctional domains approach to evaluate d1/d5 dopamine receptor partial agonism on cognition and motivation in healthy volunteers with low working memory capacity
topic Regular Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251631/
https://www.ncbi.nlm.nih.gov/pubmed/32055822
http://dx.doi.org/10.1093/ijnp/pyaa007
work_keys_str_mv AT balicegordonrita aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT honeygarryd aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT chathamchristopher aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT arceestibaliz aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT duvvurisridhar aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT naylormelissagraham aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT liuwenlei aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT xiezhiyong aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT demartinisnicholas aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT harelbriant aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT braleygabrielh aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT kozakrouba aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT parklovingly aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT graydavidl aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT balicegordonrita neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT honeygarryd neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT chathamchristopher neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT arceestibaliz neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT duvvurisridhar neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT naylormelissagraham neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT liuwenlei neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT xiezhiyong neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT demartinisnicholas neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT harelbriant neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT braleygabrielh neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT kozakrouba neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT parklovingly neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity
AT graydavidl neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity